83 research outputs found
All-in-One Mesh Hernioplasty: A New Procedure for Inguinal Hernia Repair
Since the 1970s, when biocompatible meshes were introduced with the consequent decrease of recurrence, one of the priorities in inguinal hernia surgery was that of minimizing postoperative chronic pain. All technical variations, proposed during the past years in order to improve patient’s comfort, reported a variable incidence of chronic neuralgia. The procedure we describe, applicable to all cases of primary inguinal hernia, employs a smaller pre-cut single mesh that covers all weak areas of the inguinal canal and is enveloped in a fibro-cremasteric sheath, avoiding contact of the prosthesis with neural structures. The new procedure, already performed on 250 patients, aims to improve patients’ comfort and to reduce the incidence of chronic neuralgia
Role of basophil activation test for monitoring the immunological changes during desnsitization to cow’s milk: a case report
A clinical trial of oral hyposensitization in systemic allergy to nickel.
Nickel allergy is the most common contact allergy. Some nickel-sensitive patients present systemic (cutaneous and/or digestive) symptoms related to the ingestion of high nickel-content foods, which significantly improve after a specific low nickel-content diet. The etiopathogenetic role of nickel in the genesis of systemic disorders is, furthermore, demonstrated by the relapse of previous contact lesions, appearance of widespread eczema and generalized urticaria-like lesions after oral nickel challenge test. The aim of this study is to investigate the safety and efficacy of a specific oral hyposensitization to nickel in patients with both local contact disorders and systemic symptoms after the ingestion of nickel-containing foods. Inclusion criteria for the recruitment of these patients were (other than a positive patch test) a benefit higher than 80% from a low nickel-content diet and a positive oral challenge with nickel. Based on the previous experiences, our group adopted a therapeutic protocol by using increasing oral doses of nickel sulfate associated to an elimination diet. Results have been excellent: this treatment has been effective in inducing clinical tolerance to nickel-containing foods, with a low incidence of side effects (gastric pyrosis, itching erythema)
Utility of Basophil Activation Test for monitoring the acquisition of clinical tolerance after oral desensitization to cow's milk: Pilot study
Objective: The quantification of basophil activation by flow cytometry is a useful tool for the assessment of immediate-type
responses to food allergens and the prediction of clinical tolerance in food allergy patients. The aim of this study is to
investigate how the analysis of allergen-induced CD63 up-regulation by flow cytometry can be effective in monitoring the
acquisition of clinical tolerance by specific oral desensitization in food allergy. To our knowledge, this is the first study to
examine this topic.
Materials and methods: Three male patients affected by cow’s milk allergy underwent successful oral desensitization to
cow’s milk. In order to monitor the acquired clinical tolerance that occurred after treatment, we performed laboratory tests
for total and specific IgE, specific IgG4 and the Basophil Activation Test (BAT) both at baseline and at the end of the
desensitization protocol.
Results: Using a fluorescent enzyme immunoassay, the comparison of specific cow’s milk antibodies before and after
treatment showed a decrease of specific IgE levels, without reaching normal values, and an increase of specific IgG4
levels. A complete suppression of cow’s milk proteins (a-lactoalbumin, b-lactoglobulin and casein) induced CD63 regulation
was observed in all three reported cases.
Conclusions: Using flow cytometry, food allergen-specific basophil responses could be monitored in order to identify an
acquired tolerance induced by desensitization treatment. Although further studies are needed to develop this important new
topic, it was interesting to note that the BAT seemed to be more sensitive and characterized by a close correlation with
clinical tolerance
Recommended from our members
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib
Background: Predictive biomarkers for advanced hepatocellular carcinoma are lacking. EZH2 drives sorafenib resistance through H3K27me3 and is counteracted by SETD2, which catalyzes H3K36me3. The authors tested the predictive power of circulating H3K27me3 and H3K36me3 in advanced hepatocellular carcinoma patients treated with sorafenib. Methods: A total of 80 plasma samples were tested for histone variants by ELISA. Changes from baseline to best response or progressive disease were correlated with patient survival. Results: A higher EZH2/SETD2 ratio predicted worse prognosis in this setting. H3K27me3 and H3K36me3 decreased from baseline to best response. The H3K27me3/H3K36me3 ratio increased from baseline to progressive disease. Higher ratios at best response were associated with shorter progression-free survival. Conclusion: The authors suggest that circulating H3K27me3/H3K36me3 ratio level acts as a predictive biomarker for sorafenib treatment outcomes in patients with advanced hepatocellular carcinoma
Specific oral immunotherapy in food allergic patients: transient or persistent tolerance?
Introduction: The first therapeutic choice for food allergy is avoidance of the responsible food, but when this approach is not possible, specific oral desensitization could be considered as a good alternative. It is not clear yet whether the acquired tolerance is transient or persistent. Aim: We report on a subset of 13 patients of a larger study, treated successfully with specific oral tolerance induction who experienced secondary loss of tolerance after a period of allergen avoidance. Material and methods: Thirteen patients affected by IgE-mediated food allergy: to cow milk (3 patients), to hen egg (3 patients), to cod fish (2 patients), to peanuts (1 patient) and to corn (1 patient) confirmed by a complete allergological workup and a double-blind placebo-controlled food challenge (DBPCFC), were treated with sublingual-oral desensitization. After the interruption of the maintenance phase, the laboratory tests were performed and 12 of 13 patients underwent DBPCFC. Results: Oral specific desensitization was completed successfully in all the 13 reported patients. At different times after the end of treatment, they decided, on their own initiative, to stop the ingestion of incriminated food. A new food allergen re-exposure caused adverse reactions in 12 of 13 patients. The detection of specific IgE and IgG4 during the period of allergen avoidance showed an increase in or a stable level of specific IgE and a decrease in specific IgG4 in 8 patients. Conclusions: According to our experience, the tolerance obtained through the desensitizing treatment is transient and so the regular allergen intake is necessary for its maintenance
Sensitization pattern to inhalant and food allergens in symptomatic children at first evaluation
- …